![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Table01.jpg)
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Table05.jpg)
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data | Respiratory Research | Full Text Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-018-0899-4/MediaObjects/12931_2018_899_Fig3_HTML.png)
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data | Respiratory Research | Full Text
Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study | PLOS ONE
![Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society](https://openres.ersjournals.com/content/erjor/4/4/00156-2018/F1.large.jpg)
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society
![Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/53ba76fd8c9e7a0a6259cd8ac53746cfb3b8766e/5-Table1-1.png)
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
![Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram](https://www.researchgate.net/publication/270654150/figure/fig1/AS:601751770132492@1520480210179/Summary-of-patient-classification-according-to-disease-diagnosis-and-fulfillment-of.png)
Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram
![Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,](https://journals.sagepub.com/cms/10.1177/20406223221117982/asset/images/large/10.1177_20406223221117982-fig1.jpeg)
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: Executive Summary
![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Figure02.jpg)
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Table03.jpg)
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/53ba76fd8c9e7a0a6259cd8ac53746cfb3b8766e/6-Table1-1.png)
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
![Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81591-z/MediaObjects/41598_2021_81591_Fig1_HTML.png)
Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports
![Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/13534536-e301-49f8-b30b-d043b579287f/gr1_lrg.jpg)
Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine
![National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research](https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001363/F1.large.jpg)
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research
![Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-019-0905-8/MediaObjects/12890_2019_905_Fig1_HTML.png)
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text
![Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal](https://mednexus.org/cms/asset/afbb862b-e699-4879-bece-43d6d251103f/cm9.0000000000001834.png)
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal
![IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML](https://www.mdpi.com/ijms/ijms-22-12609/article_deploy/html/images/ijms-22-12609-g001.png)
IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML
![Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/daff8330-bbd0-4379-a951-65d9d0088804/gr1_lrg.jpg)
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
![Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram](https://www.researchgate.net/publication/298797767/figure/fig2/AS:567304767639553@1512267404949/Survival-analysis-for-total-IPF-patients-according-to-GAP-stage-with-Cox-proportional.png)
Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram
![Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review | European Respiratory Society Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/4/1113/F5.large.jpg?width=800&height=600&carousel=1)
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review | European Respiratory Society
![New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-05138-6/MediaObjects/41598_2022_5138_Fig1_HTML.png)